Literature DB >> 15168153

Dermatomyositis associated with lymphoproliferative disorder of NK cells and occult small cell lung carcinoma.

Chiara M Antonioli1, Paolo Airò.   

Abstract

We report a case of dermatomyositis that was associated with a marked expansion of circulating NK cells (CD3-CD16+) with homogeneous phenotype (CD56- CD94- CD159a- CD244+) which satisfied the updated diagnostic criteria for the lymphoproliferative disorder of granular lymphocytes/NK cells. Immunosuppressive treatment induced remission of the dermatomyositis and decreased the number of circulating NK cells. However, a small cell lung carcinoma, that was occult at the time of the presentation of dermatomyositis, was diagnosed 10 months thereafter.

Entities:  

Mesh:

Year:  2004        PMID: 15168153     DOI: 10.1007/s10067-003-0814-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  10 in total

Review 1.  Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis.

Authors:  A Moretta; R Biassoni; C Bottino; M C Mingari; L Moretta
Journal:  Immunol Today       Date:  2000-05

2.  2B4 functions as a co-receptor in human NK cell activation.

Authors:  S Sivori; S Parolini; M Falco; E Marcenaro; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  2000-03       Impact factor: 5.532

Review 3.  Dermatomyositis.

Authors:  J P Callen
Journal:  Lancet       Date:  2000-01-01       Impact factor: 79.321

Review 4.  Cellular immune mechanisms in inflammatory myopathies.

Authors:  R Hohlfeld; A G Engel; N Goebels; L Behrens
Journal:  Curr Opin Rheumatol       Date:  1997-11       Impact factor: 5.006

5.  Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes.

Authors:  R Nash; P McSweeney; R Zambello; G Semenzato; T P Loughran
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

6.  Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study.

Authors:  C L Hill; Y Zhang; B Sigurgeirsson; E Pukkala; L Mellemkjaer; A Airio; S R Evans; D T Felson
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

Review 7.  Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes.

Authors:  A Moretta; R Biassoni; C Bottino; D Pende; M Vitale; A Poggi; M C Mingari; L Moretta
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

8.  The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis.

Authors:  G Semenzato; R Zambello; G Starkebaum; K Oshimi; T P Loughran
Journal:  Blood       Date:  1997-01-01       Impact factor: 22.113

9.  Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.

Authors:  R Hohlfeld; A G Engel; K Ii; M C Harper
Journal:  N Engl J Med       Date:  1991-03-28       Impact factor: 91.245

Review 10.  Large granular lymphocytosis.

Authors:  R Zambello; G Semenzato
Journal:  Haematologica       Date:  1998-10       Impact factor: 9.941

  10 in total
  7 in total

1.  Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  David E Ost; Sai-Ching Jim Yeung; Lynn T Tanoue; Michael K Gould
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 2.  The role of NK cells in rheumatoid arthritis.

Authors:  Anwar Fathollahi; Leila Nejatbakhsh Samimi; Maassoumeh Akhlaghi; Ahmadreza Jamshidi; Mahdi Mahmoudi; Elham Farhadi
Journal:  Inflamm Res       Date:  2021-09-27       Impact factor: 4.575

3.  CD56negCD16⁺ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection.

Authors:  Jeffrey M Milush; Sandra López-Vergès; Vanessa A York; Steven G Deeks; Jeffrey N Martin; Frederick M Hecht; Lewis L Lanier; Douglas F Nixon
Journal:  Retrovirology       Date:  2013-12-18       Impact factor: 4.602

4.  Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections.

Authors:  Eleonora Cimini; Domenico Viola; Mar Cabeza-Cabrerizo; Antonella Romanelli; Nicola Tumino; Alessandra Sacchi; Veronica Bordoni; Rita Casetti; Federica Turchi; Federico Martini; Joseph A Bore; Fara Raymond Koundouno; Sophie Duraffour; Janine Michel; Tobias Holm; Elsa Gayle Zekeng; Lauren Cowley; Isabel Garcia Dorival; Juliane Doerrbecker; Nicole Hetzelt; Jonathan H J Baum; Jasmine Portmann; Roman Wölfel; Martin Gabriel; Osvaldo Miranda; Graciliano Díaz; José E Díaz; Yoel A Fleites; Carlos A Piñeiro; Carlos M Castro; Lamine Koivogui; N'Faly Magassouba; Boubacar Diallo; Paula Ruibal; Lisa Oestereich; David M Wozniak; Anja Lüdtke; Beate Becker-Ziaja; Maria R Capobianchi; Giuseppe Ippolito; Miles W Carroll; Stephan Günther; Antonino Di Caro; César Muñoz-Fontela; Chiara Agrati
Journal:  PLoS Negl Trop Dis       Date:  2017-05-30

5.  Dermatomyositis Associated with Lung Neuroendocrine Carcinoma.

Authors:  Reina Takashima; Kazufumi Takamatsu; Yutaka Shinkawa; Masato Yagita; Motonari Fukui; Masaaki Fujita
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

Review 6.  NK Cell Subset Redistribution during the Course of Viral Infections.

Authors:  Enrico Lugli; Emanuela Marcenaro; Domenico Mavilio
Journal:  Front Immunol       Date:  2014-08-14       Impact factor: 7.561

7.  Ground-glass opacity heralding invasive lung adenocarcinoma with prodromal dermatomyositis: a case report.

Authors:  Andrew J Beel; David S Demos; Alfred Chung; Charles Liao; Natalie S Lui
Journal:  J Cardiothorac Surg       Date:  2018-02-07       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.